Skip to main content
Top

Diabetologia

Issue 4/1997

Content (17 Articles)

Originals

Rapid development of glomerulosclerosis in diabetic Dahl salt-sensitive rats

A. Körner, G. Jaremko, A.-C. Eklöf, A. Aperia

Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients

H. Yokoyama, O. Tomonaga, M. Hirayama, A. Ishii, M. Takeda, T. Babazono, U. Ujihara, C. Takahashi, Y. Omori

A homozygous kinase-defective mutation in the insulin receptor gene in a patient with leprechaunism

Y. Takahashi, H. Kadowaki, K. Momomura, Y. Fukushima, T. Orban, T. Okai, Y. Taketani, Y. Akanuma, Y. Yazaki, T. Kadowaki

Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects

C. Miele, P. Formisano, G. Condorelli, M. Caruso, F. Oriente, F. Andreozzi, C. G. Tocchetti, G. Riccardi, F. Beguinot

Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs

P. Poulsen, A. A. Vaag, K. O. Kyvik, D. Møller Jensen, H. Beck-Nielsen

Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM

R. Malmström, C. J. Packard, M. Caslake, D. Bedford, P. Stewart, H. Yki-Järvinen, J. Shepherd, M.-R. Taskinen

Endogenous glucose production, gluconeogenesis and liver glycogen concentration in obese non-diabetic patients

C. Müller, F. Assimacopoulos-Jeannet, F. Mosimann, P. Schneiter, J. P. Riou, C. Pachiaudi, J. P. Felber, E. Jéquier, B. Jeanrenaud, L. Tappy

Rapid communications

A mutation of the b3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride

H. Kim-Motoyama, K. Yasuda, T. Yamaguchi, N. Yamada, T. Katakura, Alan R. Shuldiner, Y. Akanuma, Y. Ohashi, Y. Yazaki, T. Kadowaki

Genetic variation in the hepatocyte nuclear factor-1a gene in Danish Caucasians with late-onset NIDDM

S. A. Urhammer, S. K. Rasmussen, P. J. Kaisaki, N. Oda, K. Yamagata, A. M. Møller, M. Fridberg, L. Hansen, T. Hansen, G. I. Bell, O. Pedersen

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.